Patients with CD133-Negative Colorectal Liver Metastasis Have a Poor Prognosis After Hepatectomy

@article{Yamamoto2014PatientsWC,
  title={Patients with CD133-Negative Colorectal Liver Metastasis Have a Poor Prognosis After Hepatectomy},
  author={Shinya Yamamoto and Kuniya Tanaka and Kazuhisa Takeda and Hirotoshi Akiyama and Yasushi Ichikawa and Yoji Nagashima and Itaru Endo},
  journal={Annals of Surgical Oncology},
  year={2014},
  volume={21},
  pages={1853-1861}
}
The prognostic factors for patients with colorectal cancer liver metastasis (L-Mets) have not been fully described. Resected specimens were obtained surgically from 1998 to 2008 at our university hospital. We investigated whether the status of two primary lesion cancer stem biomarkers, CD44 and CD133, were maintained in L-Mets and whether these markers were L-Mets prognostic factors. To investigate the CD133 and CD44 status, proliferation, invasiveness, and chemoresistance were examined… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 40 references

Primary colorectal cancers and their subsequent hepatic metastases are genetically different: implications for selection of patients for targeted treatment.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2012
View 7 Excerpts
Highly Influenced